Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. (Q51898034)

17 April 2018

title

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. (English)

1 reference

17 April 2018

0 references

1

1 reference

17 April 2018

Stephan Harbarth

series ordinal

2

object named as

Stephan Harbarth

1 reference

17 April 2018

Jean-Daniel Graf

3

1 reference

17 April 2018

Peter Rohner

series ordinal

4

1 reference

17 April 2018

Jérôme Pugin

series ordinal

5

1 reference

17 April 2018

language of work or name

English

0 references

publication date

20 December 2007

1 reference

17 April 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

17 April 2018

volume

177

1 reference

17 April 2018

issue

5

1 reference

17 April 2018

page(s)

498-505

1 reference

17 April 2018

The international sepsis forum consensus conference on definitions of infection in the intensive care unit

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Cost of Gram-negative resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Does antibiotic selection impact patient outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Meta-analysis of procalcitonin for sepsis detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

The ACCP-SCCM consensus conference on sepsis and organ failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

The future diagnostic role of procalcitonin levels: the need for improved sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Variation in antimicrobial utilization for febrile neutropenia in cancer patients. The CEMIC Study Group. Club d'Etudes des Maladies Infectieuses en Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Intensive care unit-acquired infections: is postdischarge surveillance useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Long-term reduction of vascular access-associated bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Nosocomial transmission of antibiotic-resistant microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Markers for sepsis diagnosis: what is useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200708-1238OC

10.1164/RCCM.200708-1238OC

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

18096708

1 reference

17 April 2018